A prospective randomised study comparing lateral internal sphincterotomy with anal dilatation in the treatment of anal fissures.

ISRCTN ISRCTN40397527
DOI https://doi.org/10.1186/ISRCTN40397527
Secondary identifying numbers N0084144571
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
25/11/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Not provided at time of registration

Contact information

Mr Muzaffar Ahmad
Scientific

Northern Lincolnshire & Goole Hospitals NHS Trust
Scunthorpe General Hospital
Cliff Gardens
Scunthorpe
DN15 7BH
United Kingdom

Study information

Study designProspective randomised study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeNot Specified
Scientific title
Study hypothesisAre Lateral Internal Sphincterotomy (LIS) and Anal Dilatation for the treatment of anal fissures both acceptable procedures giving equal results?
Ethics approval(s)Not provided at time of registration
ConditionSurgery: Anal fissure
InterventionPatients diagnosed as having anal fissure who have been advised to have surgery for the same, and who have agreed to such advice and fulfil the inclusion criteria will be invited to take part in the study until sample size is achieved.

Lateral internal sphincterotomy vs anal dilatation
Intervention typeProcedure/Surgery
Primary outcome measure1. The patient will be required to record all intake of Tramadol on the data collection sheet. The usage of as required medication would be used to calculate the difference in analgesic requirement between the two groups.
2. Anal incontinence will be assessed by the New St. Marks Score, extent of healing will be scored on a scale from 1 to 3, 1=no healing, 3=complete healing.
3. Pain scores on a numerical rating scale 0-10 will be collected from the patient as notes on day 1, day 5 and day 10.
Secondary outcome measuresNot provided at time of registration
Overall study start date02/06/2003
Overall study end date30/06/2004

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsThe aim of this study is to recruit 30 patients in each group to allow for patients lost to follow up and for patients who withdraw from the trial.
Participant inclusion criteriaNot provided at time of registration
Participant exclusion criteriaNot provided at time of registration
Recruitment start date02/06/2003
Recruitment end date30/06/2004

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Northern Lincolnshire & Goole Hospitals NHS Trust
Scunthorpe
DN15 7BH
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Northern Lincolnshire and Goole Hospitals NHS Trust (UK), NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan